Everybody loves a great growth stock. We all know the stories of the incredible wealth delivered by fast-growing companies that keep growing for a long period of time.
Fortunes have been made by investors who correctly selected the best growth stocks and stayed invested for a long period of time regardless of economic changes and market gyrations.
With a seemingly endless supply of news and gyrations, as we start 2025, this is one of the most important lessons we can learn from market history.
Of course, finding and holding a great growth stock is not that easy.
For every Amazon, there are a dozen Pet.Coms, eToys and Webvans.
For every Bill Gates and Steve Jobs, there are thousands of others whose stabs at technological greatness are still in a box of useless junk in the back of a garage.
Here's a new tool to help you find the growth stocks that will last.
It is not enough to find these great companies to earn massive returns. You have to hold on through the market’s ups and downs and the endless wave of BS that the media will throw at the company over the years.
In bear markets, these stocks can get crushed.
Investors who are confident enough to not just hold on but buy more stand to make the kind of gains most people only dream about.
There is a reason that very few people make as much as they should off these great growth stocks.
Finding them and then holding them for a long time is hard to do.
This is where the new Benzinga growth ranking can help you become a better growth stock investor.
I designed these ratings to help identify companies with strong long-term growth prospects.
These companies are selling more of their products and services and seeing profits grow along with revenues.
We are not looking for flash in the pan one hit wonder stocks. We want those that have been growing sales and profits and are likely to continue to do so.
Here are five companies that receive high grades from the Benzinga ranking system for growth right now:
Corporación América Airports S.A. CAAP operates a portfolio of airports across Latin America and Europe, with its crown jewel assets in Argentina. This is a textbook example of an emerging market infrastructure play with monopolistic tendencies. CAAP controls hard-to-replicate assets that directly benefit from long-term air traffic growth, tourism recovery and currency normalization.
Despite facing Argentina’s well-documented macro risks, the business has turned the corner operationally, with international diversification and cost controls setting the stage for margin expansion.
Historically, CAAP’s sales have been cyclical, heavily impacted by Argentina’s economy and global air travel disruptions like the pandemic. Revenues collapsed in 2020 but have since rebounded sharply, with 2023 sales surpassing pre-pandemic levels. Earnings have been volatile but are stabilizing, with 2023 showing significant EBITDA growth and a return to profitability. The current trajectory suggests a multi-year upside if Argentina’s economy doesn’t implode.
Blue Bird Corporation BLBD, the oldest U.S. school bus maker, has methodically pivoted into electric vehicles. While the core business is solid, the real story is the company’s leadership in EV school buses. With government funding pouring in and school districts warming up to electrification, Blue Bird is grabbing market share.
It's not flashy, but it is predictable and levered to a secular trend.
Blue Bird’s sales have historically been steady, reflecting school district budget cycles. Earnings were thin for years, but recent federal incentives for EV buses have ignited a surge in revenue and profits. Fiscal 2023 saw record sales and a massive jump in adjusted EBITDA, driven by higher pricing power and EV penetration. The company now boasts a record backlog, setting the table for continued growth.
NVIDIA Corporation NVDA has transformed from a graphics chip designer into the undisputed leader of AI infrastructure. The company’s GPUs are now essential tools for training large AI models, creating a near-insurmountable moat. Its data center segment has become the primary growth engine, dwarfing the original gaming business. NVIDIA is the shovel seller in the AI gold rush and it sells every shovel it can make.
Historically, NVIDIA has delivered incredible top-line and bottom-line growth, particularly over the past five years. Revenue soared from $11 billion in 2019 to over $60 billion in 2024, with margins expanding alongside. EPS has followed suit, driven by both sales growth and operating leverage. The recent AI boom has supercharged growth, with triple-digit year-over-year revenue increases in recent quarters.
Eli Lilly and Company LLY has morphed into a pharmaceutical juggernaut, thanks largely to its success in diabetes and obesity treatments. Drugs like Mounjaro and Zepbound are redefining the market with massive commercial potential.
Combine that with a robust pipeline and Lilly’s execution, and you’ve got a healthcare powerhouse that’s just getting warmed up.
Historically, Lilly has grown revenue steadily, but the last three years have accelerated thanks to its metabolic drugs. Sales crossed $40 billion in 2023, up from $22 billion five years prior. Earnings have also exploded, with operating margins expanding due to high-margin drug sales.
The company’s forward growth outlook remains extremely strong.
Palantir Technologies Inc. PLTR is a unique software player, originally built for government intelligence and defense but is now making serious inroads into commercial markets.
Palantir’s platforms are sticky, complex, and mission-critical, which translates into strong pricing power and customer retention.
Historically, Palantir has posted consistent revenue growth north of 20% annually since going public. Sales have risen from $743 million in 2019 to over $2 billion in 2023. The company struggled with profitability early but recently posted GAAP profits, signaling a shift toward scale. Margins are improving as commercial contracts ramp, offering a compelling long-term growth story.
Earnings and sales growth across this group are either strong or downright explosive.
CAAP is rebounding nicely as air traffic picks up and Latin American economies stabilize, with recent double-digit revenue growth.
Blue Bird is riding the EV wave, posting record sales and margins as its backlog grows.
NVIDIA is simply a rocket ship, with sales and profits more than doubling as AI demand soars.
Eli Lilly is hitting its stride with obesity drugs, driving top and bottom-line growth at a blistering pace. Palantir is scaling into profitability while maintaining impressive revenue growth, setting up years of compounding ahead.
Simply put, these are companies in the right place at the right time, and the runway for continued growth looks wide open.
Finding Undervalued Stocks & Managing Risk in a Volatile Market
Live on Tuesday, March 25, at 6 PM ET: Learn how to identify undervalued stocks with strong credit, protect your trades with options and take advantage of prime opportunities in today's volatile market with Tim Melvin, Ryan Faloona and Anne-Marie Baiynd.
Register HERE —spots are limited!
Photo: Shutterstock
Edge Rankings
Price Trend
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.